Global Stem Cell Treatments for Cancer Market

$2,600.00

产品代码: MGH01519 行业: 地区:

Cancer stem cells (CSCs) are responsible for carcinogenesis and tumorigenesis and are involved in drug and radiation resistance, metastasis, tumor relapse and initiation. 在 2021, the global stem cell treatments for cancer market stood at USD 2,074 百万. 复合年增长率为 11.8% 从 2022 到 2028, 预计价值将达到 ~USD 4,529 百万 2028, 根据 Gen Consulting 公司的一份新报告.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global stem cell treatments for cancer market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the stem cell treatments for cancer industry.

该行业报告提供了全球市场的市场估计和预测, followed by a detailed analysis of the cancer type, 和地区. The global market for stem cell treatments for cancer can be segmented by cancer type: bone cancer, brain cancer, 乳腺癌, colorectal cancer, leukemia, lung cancer, melanoma, 其他的. The breast cancer segment is estimated to account for the largest share of the global stem cell treatments for cancer market. Stem cell treatments for cancer market is further segmented by region: 亚太地区, 欧洲, 北美, 世界其他地区 (排). 北美地区占据最大的收入份额 2021.

By cancer type:
bone cancer
brain cancer
– 乳腺癌
colorectal cancer
leukemia
lung cancer
melanoma
– 其他的

按地区:
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)

The market research report covers the analysis of key stake holders of the global stem cell treatments for cancer market. Some of the leading players profiled in the report include apceth Biopharma GmbH, Benitec Biopharma Ltd., BioNTech SE, Caladrius Biosciences, 公司, Celgene Corporation, ExCellThera Inc., Fluxion Biosciences, 公司, Gamida-Cell Ltd, Genexine, 公司, ImmunoCellular Therapeutics, 有限公司, OncoCyte Corporation, OncoMed Pharmaceuticals, 公司, Pluristem Therapeutics Inc., SELLAS Life Sciences Group, 公司, Sphere Fluidics Limited, ViaCyte, 公司, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
To analyze and forecast the market size of the global stem cell treatments for cancer market.
To classify and forecast the global stem cell treatments for cancer market based on cancer type, 地区.
To identify drivers and challenges for the global stem cell treatments for cancer market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global stem cell treatments for cancer market.
To identify and analyze the profile of leading players operating in the global stem cell treatments for cancer market.

为什么选择这份报告
Gain a reliable outlook of the global stem cell treatments for cancer market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.

Global Stem Cell Treatments for Cancer Market

对这份报告感兴趣? 立即获取免费样品!
Global Stem Cell Treatments for Cancer Market - 报告范围
报告属性

细节

基准年

2021

预测年份

2022-2028

复合年增长率 (2022-2028)

11.8%

页数

87

行业参与者

apceth Biopharma GmbH, Benitec Biopharma Ltd., BioNTech SE, Caladrius Biosciences Inc., Celgene Corporation, ExCellThera Inc., Fluxion Biosciences Inc., Gamida-Cell Ltd, Genexine Inc., ImmunoCellular Therapeutics Ltd., OncoCyte Corporation, OncoMed Pharmaceuticals Inc., Pluristem Therapeutics Inc., SELLAS Life Sciences Group Inc., Sphere Fluidics Limited, ViaCyte Inc.

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - Global Stem Cell Treatments for Cancer Market

请填写我们的表格,我们会尽快回复您.